The effects of a normal protein diet on levodopa plasma kinetics in advanced Parkinson's disease.

LevoDOPA given orally may compete with the neutral aminoacids contained in food for its absorption in the small intestine. LevoDOPA plasma kinetics of the morning intake with 'french' breakfast (low protein content) were compared with those of the noon intake with lunch (normal protein content) in 20 advanced parkinsonian patients (mean disease duration: 10 years). The galenic form and the dosage of levoDOPA were strictly the same for morning and noon intakes in each patient. Blood samplings were collected at T0 (just before intake) and successively at 15, 30, 45, 60, 90, 120, 150 and 180 min after intake. LevoDOPA plasma levels were further measured with HPLC method, then giving the following variables: Cmax (peak concentration), Tmax (time corresponding to Cmax), AUC (area under curve). The results showed no significant difference for Cmax and Tmax whereas the AUC was significantly (P < 0.001) increased for the noon intake, due to the trough concentration effect. These data suggest that, since rich protein diet has been shown to impair the clinical effect of LevoDOPA, this protein effect is probably not due to competitive intestinal absorption of LevoDOPA.

[1]  J. Nutt,et al.  Erratic gastric emptying of levodopa may cause “random” fluctuations of parkinsonian mobility , 1988, Neurology.

[2]  K. Lyons,et al.  Therapy of Parkinson's disease , 1990 .

[3]  J. G. Nutt,et al.  Amount and distribution of dietary protein affects clinical response to levodopa in Parkinson's disease , 1989, Neurology.

[4]  J. Nutt,et al.  Motor fluctuations during continuous levodopa infusions in patients with Parkinson's disease , 1997, Movement disorders : official journal of the Movement Disorder Society.

[5]  R. Djaldetti,et al.  Gastric emptying in Parkinson's disease , 1996, Neurology.

[6]  F Bracco,et al.  Protein redistribution diet and antiparkinsonian response to levodopa. , 1991, European neurology.

[7]  T. Wikberg.  Simultaneous determination of levodopa, its main metabolites and carbidopa in plasma by liquid chromatography. , 1991, Journal of pharmaceutical and biomedical analysis.

[8]  T. Burks,et al.  Regulation of gastric emptying. , 1985, Federation proceedings.

[9]  J. Pincus,et al.  Protein redistribution diet restores motor function in patients with dopa‐resistant “off” periods , 1988, Neurology.

[10]  J. Nutt,et al.  Peripheral pharmacokinetics of levodopa in untreated, stable, and fluctuating parkinsonian patients , 1987, Neurology.

[11]  J. Nutt,et al.  Pharmacokinetics of levodopa. , 1984, Clinical neuropharmacology.

[12]  W R Woodward,et al.  Influence of fluctuations of plasma large neutral amino acids with normal diets on the clinical response to levodopa. , 1989, Journal of neurology, neurosurgery, and psychiatry.

[13]  M. Furlanut,et al.  Monitoring of L-dopa concentrations in Parkinson's disease. , 2001, Pharmacological research.

[14]  P. Cortelli,et al.  Pharmacodynamic modeling of oral levodopa , 1993, Neurology.

[15]  S. Grignon,et al.  Circadian phase dependent pharmacokinetics of L‐dopa, its main metabolites (3‐OMD, HVA, DOPAC) and carbidopa in rats , 1996, Fundamental & clinical pharmacology.

[16]  T. Chase,et al.  Levodopa pharmacokinetic mechanisms and motor fluctuations in Parkinson's disease , 1987, Annals of neurology.

[17]  W R Woodward,et al.  The "on-off" phenomenon in Parkinson's disease. Relation to levodopa absorption and transport. , 1984, The New England journal of medicine.

[18]  Nir Giladi,et al.  Gastric emptying time and gastric motility in patients with Parkinson's disease , 2001, Movement disorders : official journal of the Movement Disorder Society.

[19]  M. Contin,et al.  Effect of meal timing on the kinetic-dynamic profile of levodopa/carbidopa controlled is release in parkinsonian patients , 1998, European Journal of Clinical Pharmacology.

[20]  M. Engelhardt,et al.  The effect of exercise on pharmacokinetics and pharmacodynamics of levodopa , 2000, Movement disorders : official journal of the Movement Disorder Society.

[21]  A. Lang,et al.  Practical application of a low‐protein diet for Parkinson's disease , 1988, Neurology.

[22]  M. Contin,et al.  Influence of meal ingestion time on pharmacokinetics of orally administered levodopa in parkinsonian patients. , 1987, Clinical neuropharmacology.

[23]  N H Holford,et al.  The response to levodopa in parkinson's disease: Imposing pharmacological law and order , 1996, Annals of neurology.

[24]  P. Karstaedt,et al.  Protein redistribution diet remains effective in patients with fluctuating parkinsonism. , 1992, Archives of neurology.

[25]  G. C. Cotzias,et al.  Protein intake and treatment of Parkinson's disease with levodopa. , 1975, The New England journal of medicine.

[26]  W. Woodward,et al.  The effect of dietary protein on the efficacy of L‐dopa , 1989, Neurology.

[27]  T. Chase,et al.  Dietary influences on the antiparkinsonian response to levodopa. , 1987, Archives of neurology.

[28]  H. Creasey,et al.  Gastric emptying rate and the systemic availability of levodopa in the elderly parkinsonian patient , 1981, Neurology.

[29]  M. Hoehn,et al.  Parkinsonism , 1967, Neurology.

[30]  K. Lyons,et al.  Comparison of standard carbidopa–levodopa and sustained‐release carbidopa–levodopa in parkinson's disease: Pharmacokinetic and quality‐of‐life measures , 1997, Movement disorders : official journal of the Movement Disorder Society.

[31]  J. Pincus,et al.  Influence of dietary protein on motor fluctuations in Parkinson's disease. , 1987, Archives of neurology.